If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
Description
Anti-Human LINGO1 Therapeutic Antibody (Opicinumab). Recombinant monoclonal antibody to LINGO1. Opicinumab is a human monoclonal antibody that can be potentially used in the treatment of Relapsing-Remitting Multiple Sclerosis, Acute Optic Neuritis. It blocks the action of LINGO-1, allowing young cells to mature into oligodendrocytes.Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Blocking
Immunogen
n/a
Other Names
LINGO1; leucine rich repeat and Ig domain containing 1; LERN1; LRRN6A; UNQ201; leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1; leucine rich repeat neuronal 6A; leucine-rich repeat neuronal protein 1; leucine-rich repeat and immunoglobulin domain-containing protein 1